Benchimol, M, Almeida, JC, Lins, U, Gonçalves, NR and de Souza, W (1993) Electron microscopic study of the effect of zinc on Tritrichomonas foetus. Antimicrobial Agents and Chemotherapy 37, 2722–2726.
Betanzos-Lara, S, Gómez-Ruiz, C, Barrón-Sosa, LR, Gracia-Mora, I, Flores-Álamo, M and Barba-Behrens, N (2012) Cytotoxic copper(II), cobalt(II), zinc(II), and nickel(II) coordination compounds of clotrimazole. Journal of Inorganic Biochemistry 114, 82–93.
Byun, JM, Jeong, DH, Kim, YN, Lee, KB, Sung, MS and Kim, KT (2015) Experience of successful treatment of patients with metronidazole-resistant Trichomonas vaginalis with zinc sulfate: a case series. Taiwanese Journal of Obstetrics & Gynecology 54, 617–620.
Crowell, AL, Sanders-Lewis, KA and Secor, WE (2003) In vitro metronidazole and tinidazole activities against metronidazole-resistant strains of Trichomonas vaginalis. Antimicrobial Agents and Chemotherapy 47, 1407–1409.
Crowley, PD and Gallagher, HC (2014) Clotrimazole as a pharmaceutical: past, present and future. Journal of Applied Microbiology 117, 611–617.
Cudmore, SL, Delgaty, KL, Hayward-McClelland, SF, Petrin, DP and Garber, GE (2004) Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis. Clinical Microbiology Reviews 17, 783–793.
du Bouchet, L, Spence, MR, Rein, MF, Danzig, MR and McCormack, WM (1997) Multicenter comparison of clotrimazole vaginal tablets, oral metronidazole, and vaginal suppositories containing sulfanilamide, aminacrine hydrochloride, and allantoin in the treatment of symptomatic trichomoniasis. Sexually Transmitted Diseases 24, 156–160.
Debbia, EU, Campora, U, Massaro, S, Boldrini, E and Schito, GC (1996) In vitro activity of metronidazole alone and in combination with clotrimazole against clinical isolates of Trichomonas vaginalis. Journal of Chemotherapy 8, 96–101.
Edwards, DI (1993) Nitroimidazole drugs—action and resistance mechanisms. I. Mechanisms of action. Journal of Antimicrobial Chemotherapy 31, 9–20.
Figueroa-Angulo, EE, Rendón-Gandarilla, FJ, Puente-Rivera, J, Calla-Choque, JS, Cárdenas-Guerra, RE, Ortega-López, J, Quintas-Granados, LI, Alvarez-Sánchez, ME and Arroyo, R (2012) The effects of environmental factors on the virulence of Trichomonas vaginalis. Microbes and Infection 14, 1411–1427.
Goodhew, EB and Secor, WE (2013) Drug library screening against metronidazole-sensitive and metronidazole-resistant Trichomonas vaginalis isolates. Sexually Transmitted Infections 89, 479–484.
Hirt, RP (2013) Trichomonas vaginalis virulence factors: an integrative overview. Sexually Transmitted Infections 89, 439–443.
Houang, ET, Ahmet, Z and Lawrence, AG (1997) Successful treatment of four patients with recalcitrant vaginal trichomoniasis with a combination of zinc sulfate douche and metronidazole therapy. Sexually Transmitted Diseases 24, 116–119.
Krieger, JN and Rein, MF (1982) Zinc sensitivity of Trichomonas vaginalis: in vitro studies and clinical implications. The Journal of Infectious Diseases 146, 341–345.
Land, KM, Clemens, DL and Johnson, PJ (2001) Loss of multiple hydrogenosomal proteins associated with organelle metabolism and high-level drug resistance in trichomonads. Experimental Parasitology 97, 102–110.
Levy, BJ and Fair, WR (1973) The location of antibacterial activity in the rat prostatic secretions. Investigative Urology 11, 173–177.
Lewis, DA (2010) Trichomoniasis. Medicine 38, 291–293.
López Nigro, MM and Carballo, MA (2008) Genotoxicity and cell death induced by tinidazole (TNZ). Toxicology Letters 180, 46–52.
Lossick, JG and Kent, HL (1991) Trichomoniasis: trends in diagnosis and management. American Journal of Obstetrics Gynecology 165, 1217–1222.
Mammen-Tobin, A and Wilson, JD (2005) Management of metronidazole-resistant Trichomonas vaginalis-a new approach. International Journal of STD & AIDS 16, 488–490.
McGinnis, MR and Rinaldi, MG (1991) Antifungal drugs: mechanism of action, drug resistance, susceptibility testing, and assay of activity in biological fluids. In Lorian, V (ed), Antibiotics in Laboratory Medicine, 3rd edn. Baltimore, USA: Williams & Wilkins Press, pp. 198–257.
Mielczarek, E and Blaszkowska, J (2016) Trichomonas vaginalis: pathogenicity and potential role in human reproductive failure. Infection 44, 447–458.
Navarro, M, Peña, NP, Colmenares, I, González, T, Arsenak, M and Taylor, P (2006) Synthesis and characterization of new palladium–clotrimazole and palladium–chloroquine complexes showing cytotoxicity for tumor cell lines in vitro. Journal of Inorganic Biochemistry 100, 152–157.
Navarro, M, Higuera-Padilla, AR, Arsenak, M and Taylor, P (2009) Synthesis, characterization, DNA interaction studies and anticancer activity of platinum clotrimazole complexes. Transition Metal Chemistry 34, 869–875.
Rocha, DA, de Andrade Rosa, I, de Souza, W and Benchimol, M (2014 a) Evaluation of the effect of miltefosine on Trichomonas vaginalis. Parasitology Research 113, 1041–1047.
Rocha, DA, de Andrade Rosa, I, Urbina, JA, de Souza, W and Benchimol, M (2014 b) The effect of 3-(biphenyl-4-yl)-3-hydoxyquinuclidine (BPQ-OH) and metronidazole on Trichomonas vaginalis: a comparative study. Parasitology Research 113, 2185–2197.
Rosa, IA, Rocha, DA, de Souza, W, Urbina, JA and Benchimol, M (2011) Ultrastructural alterations induced by Δ(24(25))-sterol methyltransferase inhibitors on Trichomonas vaginalis. FEMS Microbiology Letters 315, 72–78.
Schwebke, JR and Barrientes, FJ (2006) Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole. Antimicrobial Agents and Chemotherapy 50, 4209–4210.
Secor, WE (2012) Trichomonas vaginalis: treatment questions and challenges. Expert Review of Ant-Infective Therapy 10, 107–109.
Upcroft, JA and Upcroft, P (2001) Drug susceptibility testing of anaerobic protozoa. Antimicrobial Agents and Chemotherapy 45, 1810–1814.
Vazquez-Carrillo, LI, Quintas-Granados, LI, Arroyo, R, Mendoza-Hernández, G, González-Robles, A, Carvajal-Gamez, BI and Alvarez-Sánchez, ME (2011) The effect of Zn2þ on prostatic cell cytotoxicity caused by Trichomonas vaginalis. Journal of Integrated OMICS 1, 198–210.
Workowski, KA and Berman, S and Centers for Disease Control and Prevention (2010). Sexually transmitted diseases treatment guidelines. MMWR Recommendations and Reports 59, 1–110.
World Health Organization (2012) Global Incidence and Prevalence of Selected Curable Sexually Transmitted Infections – 2008. Genebra: WHO Press.
Wright, JM, Webb, RI, O'Donoghue, P, Upcroft, P and Upcroft, JA (2010) Hydrogenosomes of laboratory-induced metronidazole-resistant Trichomonas vaginalis lines are downsized while those from clinically metronidazole-resistant isolates are not. Journal of Eukaryotic Microbiology 57, 171–176.